2.35
Finanzdaten der Cardiff Oncology Inc-Aktie (CRDF)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
11.01%
0.121
|
0.109 | 0.165 | 0.163 | 0.205 |
|
|
2.81%
14.90
|
14.49 | 12.77 | 12.71 | 11.14 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
2.81%
14.90
|
14.49 | 12.77 | 12.71 | 11.14 |
| Operating Income/Loss |
2.75%
-14.78
|
-14.38 | -12.60 | -12.54 | -10.93 |
| Nonoperating Income/Loss |
12.03%
0.834
|
0.948 | 0.746 | 0.767 | 0.922 |
| Income/Loss From Continuing Operations Before Tax |
100.90%
0.121
|
-13.43 | 0.165 | -11.78 | -10.01 |
| Income/Loss From Continuing Operations After Tax |
3.79%
-13.94
|
-13.43 | -11.86 | -11.78 | -10.01 |
|
|
3.79%
-13.94
|
-13.43 | -11.86 | -11.78 | -10.01 |
| Preferred Stock Dividends And Other Adjustments |
0.006
|
- | 0.006 | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.00%
66.53
|
66.52 | 46.87 | 44.83 | 44.68 |
| Diluted Average Shares |
0.00%
66.53
|
66.52 | 46.87 | 44.83 | 44.68 |
| Basic Earnings Per Share |
5.00%
-0.21
|
-0.20 | -0.25 | -0.26 | -0.22 |
| Diluted Earnings Per Share |
5.00%
-0.21
|
-0.20 | -0.25 | -0.26 | -0.22 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
0.006
|
- | 0.006 | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):